Clinical trial
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly…
NCT00499798 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00499798 |
|---|---|
| Title | Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
| Official title | Temozolomide Induced Changes in Semen/Sperm Analysis in Men With Newly Diagnosed, Progressive or Recurrent Primary Malignant Brain Tumors |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Brain and Central Nervous System Tumors, Chemotherapeutic Agent Toxicity, Infertility |
| Enrollment | 16 |
| Start date | Aug 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Sep 1, 2014 |
| First posted | Jul 11, 2007 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: